Clinical trials
Inflammatory Disease clinical trials
Below are recruiting inflammatory disease clinical trials, each written for real people, not researchers. We’re tracking 441 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07047339RecruitingPhase 2/Phase 3
Probiotic 6600 for colitis patients
This trial tests whether adding Probiotic 6600 to your usual treatment can help manage colitis, including ulcerative colitis or Crohn's disease. It aims to see if the probiotic improves symptoms and is safe to use.
ShanghaiAges 18–75 - NCT07162701Recruiting
Body composition study for inflammatory bowel disease
This study looks at body composition (fat and muscle) in people with Crohn's disease or ulcerative colitis. It tests if a new way to monitor body changes can help guide treatment with biologic or JAK inhibitor medicines.
BarcelonaAges 18–64 - NCT07168499Recruiting
Diet, stress, and advanced therapy for Crohn's and colitis
This study tests whether adding a diet and stress management program to standard advanced therapy helps people with active Crohn's disease or ulcerative colitis feel better. It combines lifestyle changes with new medications to improve treatment outcomes.
Boston, MassachusettsAges 18 years+ - NCT07174843RecruitingEarly Phase 1
CAR-T cell therapy for autoimmune diseases
This study tests a new type of cell therapy called CAR-T cells that target three proteins (CD19, CD22, BCMA) to treat people with autoimmune diseases that have not responded to standard treatments. The goal is to see if it can reset the immune system and reduce disease activity.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT07207200Recruiting
Morning light therapy for ulcerative colitis
This study tests whether morning light therapy can help reduce inflammation in people with ulcerative colitis. It may be an option if you have active inflammation and can attend light sessions.
New York, New YorkAges 18 years+ - NCT07230262Recruiting
Robotic vs. laparoscopic surgery for IBD patients
This study compares two types of minimally invasive surgery—robotic and laparoscopic—for people with inflammatory bowel disease (Crohn's or ulcerative colitis) who need elective colon or rectal surgery. It aims to find out which approach might be better for recovery and outcomes.
Leuven, Vlaams BrabantAges 18 years+ - NCT07252427Recruiting
Gut bacteria in IBD with or without depression
This study looks at how the bacteria in your gut (gut microbiome) may differ between people with IBD who also have depression and those who don't. It aims to help understand the link between gut health and mood.
Jinan, ShandongAges 18 years+ - NCT07335705Recruiting
Factors affecting bowel prep in IBD patients
This study looks at factors that affect how well the bowel is cleaned before a colonoscopy in people with IBD. The goal is to improve preparation so the colonoscopy can be more effective.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07304154RecruitingPhase 1
Study of KITE-363 for autoimmune nerve diseases
This trial tests a new treatment called KITE-363 for people with certain autoimmune nerve diseases, such as multiple sclerosis, myasthenia gravis, or chronic inflammatory demyelinating polyneuropathy, that have not responded well to standard therapies. The goal is to see if it is safe and effective.
Palo Alto, CaliforniaAges 18–75 - NCT07349472RecruitingPhase 2
Pentoxifylline for ulcerative colitis
This trial tests if the drug pentoxifylline can help people with mild to moderate ulcerative colitis. It may offer a new treatment option for those not on other strong medications.
Al FayyumAges 18–70 - NCT07373457RecruitingPhase 1
Testing a new drug in healthy volunteers
This early-stage study tests a new investigational drug called HW201877 in healthy volunteers. The goal is to see if the drug is safe and how the body processes it.
ChangchunAges 18–55 - NCT01650311Recruiting
Study how serotonin signals work in inflammatory bowel disease
This study looks at how the body’s serotonin system behaves in people with Crohn’s disease or ulcerative colitis, compared with healthy people. It may help researchers understand disease biology and why symptoms can differ from person to person.
Hamilton, OntarioAges 19–85 - NCT01581294Recruiting
Norwegian arthritis drug registry for new biologic or kinase treatment
This study is a real-world registry that follows adults with inflammatory arthritis when they start a new targeted medicine. It helps researchers understand how these drugs work in everyday care.
Drammen, BuskerudAges 18 years+ - NCT02614911Recruiting
Genetics and health profile study for early severe bowel disease
This study looks at how an early-onset bowel illness looks and what genetic changes may be involved. It may help researchers better understand inherited causes and improve future care for families affected by these conditions.
BordeauxAges Any age - NCT03358693Recruiting
Study of inflammation patterns in chronic skin diseases
This study looks at molecular (body-level) signatures in people with chronic inflammatory skin conditions. You may help researchers understand what drives inflammation, while receiving standard (already approved) systemic treatment through routine care.
KielAges Any age - NCT07401680RecruitingPhase 1
Stool transplant for active ulcerative colitis
This trial tests whether a stool transplant (fecal microbiota transplantation) can help manage active ulcerative colitis. You would receive a transplant from a healthy donor to see if it improves your symptoms.
Calgary, AlbertaAges 18 years+ - NCT07423000RecruitingPhase 1
Testing PVT401 in healthy volunteers
This study tests a new investigational drug called PVT401 in healthy people. It is a first-in-human study to see how the drug is handled by the body and to check for any side effects.
Melbourne, VictoriaAges 18–65 - NCT07591012Recruiting
Probiotic Supplements for Ulcerative Colitis Remission
This trial tests whether taking sodium butyrate (a short-chain fatty acid) and a specific probiotic yeast called Kluyveromyces marxianus can help keep ulcerative colitis in remission and prevent flare-ups. You'd need to be in remission (symptom-free with no active inflammation) when you start.
PadovaAges 18–75 - NCT07619638Recruiting
Microbiome Supplement for Mild-to-Moderate Ulcerative Colitis
This trial tests a specially designed supplement that aims to restore healthy gut bacteria in people with mild-to-moderate ulcerative colitis. The goal is to reduce inflammation and improve symptoms like rectal bleeding and bowel urgency.
IzmirAges 18–75 - NCT07475052Enrolling by invitation
Heart rate monitoring to predict biologic therapy response in IBD
This study tests whether a wearable heart rate monitor can help predict how well biologic medications work for people with Crohn's disease or ulcerative colitis. If you are starting infliximab or vedolizumab for the first time, you may be eligible.
Xi'an, ShaanxiAges 18–75 - NCT07221565Enrolling by invitationPhase 1/Phase 2
Immune mapping trial for autoimmune conditions
This trial is testing a new way to map the immune system using electromagnetic signals and forecast how your body's immune system will respond. It may help people with autoimmune conditions like lupus or rheumatoid arthritis find new treatment options.
New York, New YorkAges Any age - NCT06763783Enrolling by invitationPhase 4
Shingles vaccine study for people with rheumatic diseases
This study offers the Shingrix shingles vaccine for free to adults with inflammatory rheumatic diseases. It compares how well the vaccine works in people taking immune-suppressing drugs versus those not taking them.
LundAges 18 years+ - NCT06179563Enrolling by invitation
On-demand app for IBD patients in remission
This trial tests an app that lets you check in with your IBD care team only when you need to, instead of having regular appointments. It's for people with Crohn's disease or ulcerative colitis who are doing well and have been on the same medication for at least 3 months.
's-Hertogenbosch, North BrabantAges 18 years+ - NCT03976622Enrolling by invitation
Inflammation study in vitiligo and other skin conditions
This study looks at inflammation in people with vitiligo, psoriasis, atopic dermatitis, or alopecia areata. It aims to understand how these conditions compare, which may lead to better treatments.
Bordeaux, BordeauxAges 18–75
Hear when a new Inflammatory Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for inflammatory disease?
- Yes. Clin2 currently lists 441 recruiting inflammatory disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a inflammatory disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a inflammatory disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.